Tempest Therapeutics shares head back to earth after 4000% gain - Morningstar

Retrieved on: 2023-10-12 16:55:49

Tags for this article:

Dow Jones & Company

S&P Dow Jones Indices

Tempest

Dow

Tyrosylprotein sulfotransferase

MarketWatch

Atezolizumab

Tempest Therapeutics Inc.

Click the tags to see associated articles and topics

Tempest Therapeutics shares head back to earth after 4000% gain - Morningstar. View article details on HISWAI: https://www.morningstar.com/news/marketwatch/20231012408/tempest-therapeutics-shares-head-back-to-earth-after-4000-gain

Excerpt

The drug candidate, when combined with the Roche Holding AG (RHHBY) monoclonal antibodies Tecentriq and Avastin, showed clinical superiority in ...

Article found on: www.morningstar.com

View Original Article